Zobrazeno 1 - 10
of 143
pro vyhledávání: '"H J, Kuijpers"'
Autor:
Bart Koopman, Chantal C. H. J. Kuijpers, Harry J. M. Groen, Wim Timens, Ed Schuuring, Stefan M. Willems, Léon C. van Kempen
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 668 (2022)
Gene fusions involving NTRK1, NTRK2, and NTRK3 are rare drivers of cancer that can be targeted with histology-agnostic inhibitors. This study aimed to determine the nationwide landscape of NTRK/TRK testing in the Netherlands and the usage of pan-TRK
Externí odkaz:
https://doaj.org/article/4163d8a721c54c0cae77f51cbd47b9db
Publikováno v:
Histopathology, 82(2), 254-263. Wiley-Blackwell
Histopathology, 82, 2, pp. 254-263
Histopathology, 82, 254-263
Histopathology, 82, 2, pp. 254-263
Histopathology, 82, 254-263
Contains fulltext : 291049.pdf (Publisher’s version ) (Open Access) The introduction of bowel cancer population screening programs has had a profound impact on gastrointestinal pathology. While the focus is mainly on quality assurance of diagnoses
Autor:
Bart, Koopman, Chantal C H J, Kuijpers, Harry J M, Groen, Wim, Timens, Ed, Schuuring, Stefan M, Willems, Léon C, van Kempen
Publikováno v:
Diagnostics (Basel, Switzerland). 12(3)
Gene fusions involving
Autor:
Ed Schuuring, Ronald A M Damhuis, Chantal C H J Kuijpers, Harry J.M. Groen, Anthonie J. van der Wekken, Léon C van Kempen, Bart Koopman, Stefan M. Willems, Betzabel N. Cajiao Garcia
Publikováno v:
Cancers, 13(14):3641. MDPI AG
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3641, p 3641 (2021)
Cancers
Volume 13
Issue 14
Cancers, Vol 13, Iss 3641, p 3641 (2021)
EGFR mutation analysis in non-small-cell lung cancer (NSCLC) patients is currently standard-of-care. We determined the uptake of EGFR testing, test results and survival of EGFR-mutant NSCLC patients in the Netherlands, with the overall objective to c
Autor:
Bart, Koopman, Betzabel N, Cajiao Garcia, Chantal C H J, Kuijpers, Ronald A M, Damhuis, Anthonie J, van der Wekken, Harry J M, Groen, Ed, Schuuring, Stefan M, Willems, Léon C, van Kempen
Publikováno v:
Cancers
Simple Summary The presence of an EGFR activating mutation in tumors of non-small-cell lung cancer patients enables effective targeted therapy towards EGFR. Studies that describe a nationwide uptake of EGFR testing, the impact of the switch from sing
Autor:
Chantal C H J Kuijpers, Cathy B Moelans, Henk-Jan van Slooten, Anja Horstman, John W J Hinrichs, Shaimaa Al-Janabi, Paul J van Diest, Mehdi Jiwa
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e82018 (2013)
BackgroundHER-2 is a prognostic and predictive marker, but as yet no technique is perfectly able to identify patients likely to benefit from HER-2 targeted therapies. We aimed to prospectively assess the added value of first-line co-testing by IHC, a
Externí odkaz:
https://doaj.org/article/1f6119dbaea041c9aea6bb77eb8da9b5
Autor:
Maarten Te, Groen, Monica E W, Derks, Chantal C H J, Kuijpers, Iris D, Nagtegaal, Frank, Hoentjen
Publikováno v:
Gastroenterology.
Autor:
Chantal C H J Kuijpers, Stefan M. Willems, Jules L. Derks, Ronald A M Damhuis, M. van den Heuvel, Lizza E.L. Hendriks, A. Van Lindert, Anne-Marie C. Dingemans
Publikováno v:
Lung Cancer, 121, 76. Elsevier Ireland Ltd
Lung Cancer, 121, pp. 76-81
Lung Cancer, 121, 76-81
Lung Cancer, 121, 76-81. Elsevier Ireland Ltd
Lung Cancer, 121, 76-81. ELSEVIER IRELAND LTD
Lung Cancer, 121, pp. 76-81
Lung Cancer, 121, 76-81
Lung Cancer, 121, 76-81. Elsevier Ireland Ltd
Lung Cancer, 121, 76-81. ELSEVIER IRELAND LTD
Contains fulltext : 193662.pdf (Publisher’s version ) (Open Access) OBJECTIVES: Biological predisposition for specific metastatic organs might differ between molecular subgroups of lung cancer. We aimed to assess the association between molecular s
Autor:
Lucy I.H. Overbeek, Ivette A. G. Deckers, Chantal C H J Kuijpers, Paul J. van Diest, Stefan M. Willems, Carmen van Dooijeweert
Publikováno v:
Breast Cancer Research and Treatment, 174(2), 479. Springer New York
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment
Purpose A considerable part of ductal carcinoma in situ (DCIS) lesions may never progress into invasive breast cancer. However, standard treatment consists of surgical excision. Trials aim to identify a subgroup of low-risk DCIS patients that can saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6a828646d6ba908a87311d1ab9df7b
https://dspace.library.uu.nl/handle/1874/391824
https://dspace.library.uu.nl/handle/1874/391824
Autor:
Martijn G.H. van Oijen, Stefan M. Willems, Mehdi Jiwa, Chantal C H J Kuijpers, Jan H. von der Thüsen, Katrien Grünberg, Paul J. van Diest, Lucy I H Overbeek, Caro E. Sluijter, Iris D. Nagtegaal
Publikováno v:
American Journal of Surgical Pathology, 40(8), 1100. Lippincott Williams and Wilkins
American Journal of Surgical Pathology, 40(8), 1100-1108. Lippincott Williams & Wilkins
American journal of surgical pathology, 40(8), 1100-1108. Lippincott Williams and Wilkins
American Journal of Surgical Pathology, 40(8), 1100-1108. Lippincott Williams & Wilkins
American journal of surgical pathology, 40(8), 1100-1108. Lippincott Williams and Wilkins
Differentiation grade of colorectal adenocarcinoma (CRC) is a prognostic factor and important for therapy selection. In patients with stage II colon cancer, poor differentiation is an indication for adjuvant chemotherapy. The variability in daily pra